NCI/NIBIB SynBio & Cancer Series: Advances and Aspirations (Registration)

Submitted by nusratyj on

Registration

 

OMB No.: 0925-0740
Expiration Date: 11/30/2028

Public reporting burden for this collection of information is estimated to average 3 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Your Information
Title
Suffix
Additional Registration Questions
AND-gated Synthetic Biomarkers for Early Detection of Liver Metastasis, PIs: Gabriel Kwong and Peng Qiu (Georgia Institute of Technology)
Immunotherapy via Engineered Therapeutic Programs in Tumors Using RNA, PIs: Ron Weiss (Massachusetts Institute of Technology), Yizhou Dong (Icahn School of Medicine at Mount Sinai), Darrell Irvine (Scripps Research Institute)
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer, PI: Amir Zarrinpar (University of California, San Diego)
Selection Gene Drives for Cancer Therapy, PI: Justin Pritchard (Pennsylvania State University)
Precise Tumor Targeting with Logic CAR Circuits, PIs: Wilson Wong (Boston University), Yolonda Colson (Massachusetts General Hospital), Mark Grinstaff (Boston University)
Synthetic Circuits that Drive Infiltration of Therapeutic T Cells into Immunologically Cold Tumors, PIs: Wendell Lim and Hana El-Samad (University of California, San Francisco)
Request for Reasonable Accommodations